Seasoned international trade and intellectual property attorney Charles Schill has joined national law firm Steptoe & Johnson LLP's Washington office as a partner.
Wockhardt becomes the first domestic Indian drug maker to secure an exclusive marketing right as the government grants an EMR for its topical anti-bacterial drug Nadoxin.
Once again, Brazil's government is playing hardball in its efforts to get deep discounts on anti-HIV drugs.
India’s government introduced its patent bill ahead of schedule, seeking to bring the country into compliance with its international obligations regarding intellectual property rights by 2005.
Indian drug companies are lobbying the government for an exemption from patent infringement provisions in amendments to the country’s patent law for drugs already in the market.
Arizona-based chip equipment maker seeks to block importation of Malaysian rival's products.
Government approves introduction of bills aimed at securing TRIPS compliance and stiffen penalties for drug counterfeiting.
The European Parliament adopts sweeping new legislation aimed at standardizing regulatory data protection for drugs across the European Union.
F. Leslie Bessenger, III, Houtan K. Esfahani, Esther H. Lim, Michael A. Morin, Erik R. Puknys, and Douglas A. Rettew will assume their new positions on January 1, 2004.
Similar suits against 3com, Agere Systems, Lucent Technologies and U.S. Robotics are still proceeding.
Bill would extend pharma patents but would leave rules on compulsory licensing and patentability intact, sources say.
Brazilian government continues to play hardball with HIV/AIDS drug makers after winning record discount from Bristol-Myers Squibb last month.
International Trade Commission cites federal court decision that found technology did not violate the Digital Millennium Copyright Act.
Senior officials meet to discuss growing problem as U.S., Japanese and European automakers complain their product designs are being copied.
Legal actions are unrelated to the 1997 patent infringement suit over a different transmission system that Eaton filed against Rockwell International.
In a policy reversal, India’s government is expected to propose data protection for a period of three to five years for pharmaceutical inventors.
Revised language would strip patents from legislation and remove criminal sanctions for copyright infringement.
Ten IP attorneys in Chicago, Los Angeles and New York among 52 associates promoted to partnership.
E.U. negotiators walk away from talks after U.S. proposes open access to geographic names such as Champagne and Chianti.
In a setback for U.S. industry groups and Bush administration, final draft on Free Trade Area of the Americas leaves out agreement on hemisphere-wide intellectual property protection.